On Oct. 1, MicroMed Cardiovascular, manufacturer of the HeartAssist 5 left ventricular assist device (LVAD), announced that Ash Attia has joined the company as Vice President of Asia-Pacific. Attia will be responsible for the launch, management and expansion of the HeartAssist 5 in the region, which includes China, Japan, India, Southeast Asia, Australia and New Zealand.
“Ash has more than 20 years of experience in medical devices and expanding cutting edge technology into the Asia-Pacific region,” says Bill Birdsall, MicroMed CEO. “His knowledge and leadership are critical to bringing the HeartAssist 5 to an underserved patient population in need of our life-saving technology.”
Attia (photo) has held several senior executive roles within the medical devices industry. Most recently, Attia held the position of Vice President of Asia-Pacific for Ventracor Limited, an Australian manufacturer of ventricular assist devices.
Prior to Ventracor, Attia founded Biotronik Australia and subsequently Biotronik Asia Pacific. As Vice President and Managing Director, he expanded business throughout the region in Cardiac Rhythm Management devices, Vascular Interventions and Electrophysiology.
Prior to this, Attia was General Manager of Sulzer International’s Cardiovascular division, where he managed a group of companies in the areas of Cardiac Rhythm Management, Vascular devices, Cardiac Surgery and Electrophysiology.
The HeartAssist 5 pump weighs 92g and measures 2.8" x 1.2". Because of its miniature size, it is one of the few LVADs that can be implanted above the diaphragm, adjacent to the heart. The HeartAssist 5 is the only LVAD with a precise, direct flow measurement system.
For more information, please visit http://www.micromedcv.com